@conference{858b659e43254a57bac7178d7f99954c,
title = "ANG1005, a novel brain-penetrant taxane derivative, for the treatment of recurrent brain metastases and leptomeningeal carcinomatosis from breast cancer.",
author = "Priya Kumthekar and Shou-Ching Tang and Brenner, \{Andrew Jacob\} and Santosh Kesari and Piccioni, \{David Eric\} and Anders, \{Carey K.\} and Carrillo, \{Jose Arganda\} and Pavani Chalasani and Peter Kabos and Shannon Puhalla and Garcia, \{Agustin A.\} and Tkaczuk, \{Katherine Hanna\} and Ahluwalia, \{Manmeet Singh\} and Lakhani, \{Nehal J.\} and Ibrahim, \{Nuhad K.\}",
note = "2004 Background: Treatment options for brain metastases (BM) and leptomeningeal carcinomatosis (LC) are limited due to the inability of most anti-cancer agents to cross the blood-brain barrier (BBB) and the blood-cerebrospinal fluid barrier (BCB).; Journal of Clinical Oncology ; Conference date: 01-01-2020",
year = "2016",
month = may,
day = "20",
doi = "10.1200/JCO.2016.34.15\_SUPPL.2004",
language = "American English",
}